Zdrowie i gospodarka · 16/02/1996

FDA Proposes Amendment to Investigational New Drug Regulation

The Food and Drug Administration (FDA) is proposing to amend its regulation that disqualifies clinical investigators who submit false information, aiming to clarify the agency's authority to take action against sponsors.